Melissa A. Ashlock
2015
In 2015, Melissa A. Ashlock earned a total compensation of $1M as Former Senior Vice President Translational Medicine and Therapeutics at aTYR PHARMA.
Compensation breakdown
| Non-Equity Incentive Plan | $84,110 |
|---|---|
| Option Awards | $642,552 |
| Salary | $291,188 |
| Other | $5,797 |
| Total | $1,023,647 |
Ashlock received $642.6K in option awards, accounting for 63% of the total pay in 2015.
Ashlock also received $84.1K in non-equity incentive plan, $291.2K in salary and $5.8K in other compensation.
Rankings
In 2015, Melissa A. Ashlock's compensation ranked 7,834th out of 13,638 executives tracked by ExecPay. In other words, Ashlock earned more than 42.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,834 out of 13,638 | 43rd |
Division Manufacturing | 2,970 out of 5,190 | 43rd |
Major group Chemicals And Allied Products | 1,072 out of 1,854 | 42nd |
Industry group Drugs | 865 out of 1,528 | 43rd |
Industry Biological Products, Except Diagnostic Substances | 144 out of 254 | 43rd |
Source: SEC filing on April 12, 2016.
Ashlock's colleagues
We found three more compensation records of executives who worked with Melissa A. Ashlock at aTYR PHARMA in 2015.